GLP1R and Sepsis: In 331,863 matched GLP-1 RA users, pneumonia (HR 0.60, 95% CI 0.58–0.62) and severe sepsis (HR 0.61, 95% CI 0.59–0.63) risks were significantly reduced compared to the DPP-4i arm.